Microbiome-focused asthma management strategies

Publication Type:
Journal Article
Current Opinion in Pharmacology, 2019, 46 pp. 143 - 149
Issue Date:
Filename Description Size
1-s2.0-S1471489219300025-main.pdfPublished Version1.01 MB
Adobe PDF
Full metadata record
© 2019 Elsevier Ltd Asthma is a common, heterogeneous and serious disease with high prevalence globally. Poorly controlled, steroid-resistant asthma is particularly important as there are no effective therapies and it exerts substantial healthcare and societal burden. The role of microbiomes, particularly in chronic diseases has generated considerable interest in recent times. Existing evidence clearly demonstrates an association between asthma initiation and the microbiome, both respiratory and gastro-intestinal, although its’ roles are poorly understood when assessing the asthma progression or heterogeneity (i.e. phenotypes/endotypes) across different geographical locations. Moreover, modulating microbiomes could be preventive and/or therapeutic in patients with asthma warrants urgent attention. Here, we review recent advances in assessing the role of microbiomes in asthma and present the challenges associated with the potential therapeutic utility of modifying microbiomes in management.
Please use this identifier to cite or link to this item: